{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "New York",
      "state": "NY",
      "country": "United States",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "NDA018276"
        ],
        "brand_name": [
          "XANAX"
        ],
        "generic_name": [
          "ALPRAZOLAM"
        ],
        "manufacturer_name": [
          "PHARMACIA & UPJOHN COMPANY LLC"
        ],
        "product_ndc": [
          "0009-0029",
          "0009-0055",
          "0009-0090",
          "0009-0094"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "ALPRAZOLAM"
        ],
        "rxcui": [
          "141927",
          "141928",
          "197321",
          "197322",
          "214003",
          "214004",
          "308047",
          "308048"
        ],
        "spl_id": [
          "f5323eac-81d0-4096-ac15-2f25220c5c28"
        ],
        "spl_set_id": [
          "388e249d-b9b6-44c3-9f8f-880eced0239f"
        ],
        "package_ndc": [
          "0009-0029-01",
          "0009-0029-46",
          "0009-0029-02",
          "0009-0029-14",
          "0009-0055-01",
          "0009-0055-46",
          "0009-0055-03",
          "0009-0055-15",
          "0009-0090-01",
          "0009-0090-04",
          "0009-0090-13",
          "0009-0094-01",
          "0009-0094-03"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0300090094010",
          "0300090090012",
          "0300090029012",
          "0300090055011"
        ],
        "nui": [
          "N0000175694",
          "M0002356"
        ],
        "pharm_class_epc": [
          "Benzodiazepine [EPC]"
        ],
        "pharm_class_cs": [
          "Benzodiazepines [CS]"
        ],
        "unii": [
          "YU55MQ3IZY"
        ]
      },
      "product_type": "Drugs",
      "event_id": "72199",
      "recalling_firm": "Pfizer Inc.",
      "address_1": "235 East 42nd Street",
      "address_2": "N/A",
      "postal_code": "10017-5703",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0161-2016",
      "product_description": "Xanax (alprazolam) tablets, 0.25 mg, 100-count bottle, Rx only, Distributed by Pharmacia & Upjohn Co. Division of Pfizer Inc, NY, NY 10017, NDC 0009-0029-01",
      "product_quantity": "21,120 HDPE bottles",
      "reason_for_recall": "Subpotent Drug",
      "recall_initiation_date": "20150924",
      "center_classification_date": "20151029",
      "termination_date": "20170508",
      "report_date": "20151104",
      "code_info": "Lot # C111054; Exp. 02/16"
    }
  ]
}